Envoy Medical Inc Ordinary Shares - Class A COCH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
-
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
-
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street
Trading Information
- Previous Close Price
- $0.65
- Day Range
- $0.63–0.65
- 52-Week Range
- $0.36–1.89
- Bid/Ask
- $0.64 / $0.66
- Shares Outstanding
- 77.02M
- Market Cap
- $49.94M
- Volume/Avg
- 51,459 / 204,251
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 62.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 47
- Website
- https://www.envoymedical.com
Valuation
|
Metric
|
COCH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.75 |
Price/Sales | 62.42 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
COCH
|
|---|---|
Quick Ratio | 2.07 |
Current Ratio | 2.27 |
Interest Coverage | −20.10 |
Quick Ratio
COCH
Profitability
|
Metric
|
COCH
|
|---|---|
Return on Assets (Normalized) | −174.69% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
COCH
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Tjbryvls | Vqglvg | $154B | |||
| Stryker Corp
SYK
| Nvydwwtgxg | Rvl | $120B | |||
| Medtronic PLC
MDT
| Hfytdpkw | Byrmzb | $103B | |||
| Boston Scientific Corp
BSX
| Bnvngfvq | Fdwtdg | $70B | |||
| Edwards Lifesciences Corp
EW
| Wshpwyxhg | Pnkxdty | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Jwrsggksp | Lkdp | $30B | |||
| DexCom Inc
DXCM
| Hghzvggx | Whbxqm | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Vgphk | Xnx | $26B | |||
| Steris PLC
STE
| Xtmhkxd | Dnjfx | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mjpnydtslt | Kcqs | $17B |
United States